СОХРАНЯЮЩАЯСЯ ДИСФУНКЦИЯ ЭНДОТЕЛИЯ У ПАЦИЕНТОК С РАННЕЙ ПРЕЭКЛАМПСИЕЙ В АНАМНЕЗЕ И ОСОБЕННОСТИ ПРЕГРАВИДАРНОЙ ПОДГОТОВКИ

Библиографические ссылки:

Кузнецова И.В., Гаврилова Е.А. Клинический опыт коррекции эндотелиальной дисфункции на этапе подготовки к беременности больных синдромом поликистозных яичников. Эффективная фармакотерапия. 2020; 16(28): 36–40. [Kuznetsova I.V., Gavrilova E.A. Clinical experience in the correction of endothelial dysfunction in patients with polycystic ovary syndrome in preparation for pregnancy. Effective pharmacotherapy. 2020; 16(28): 36-40. (In Russ.)]

Кузнецова И.В. Роль преконцепционной эндотелиальной дисфункции в развитии акушерских осложнений. Медицинский алфавит. 2019; 1(1): 53-58.https://doi.org/10.33667/2078-5631-2019-1-1(376)-53-58 [Kuznetsova I.V. The role of preconceptional endothelial dysfunction in the development of obstetric complications. Medical Alphabet. 2019; 1(1): 53-58.https://doi.org/10.33667/2078-5631-2019-1-1(376)-53-58 (In Russ.)]

Прегравидарная подготовка: клинический протокол /авт.- разраб. В.Е. Радзинский и др. М.: Редакция журнала StatusPraesens. 2016; 80с. [Pregravidarial preparation: a clinical protocol/author-developer. Radzinsky et al. Moscow: Editorial Board of StatusPraesens. 2016; 80p. (In Russ.)]

Преэклампсия. Эклампсия. Отеки, протеинурия и гипертензивные расстройства во время беременности, в родах и послеродовом периоде. Клинические рекомендации. 2021. [Preeclampsia. Eclampsia. Edema, proteinuria and hypertensive disorders during pregnancy, labor and the postpartum period. Clinical guidelines. 2021. (In Russ.)]

Akhter T., Wikström A.K., Larsson M., et al. Association between angiogenic factors and signs of arterial aging in women with pre-eclampsia. Ultrasound Obstet. Gynecol. 2017; 50: 93–99. doi: 10.1002/uog.15981

Brewster LM, Garcia VP, Levy MV, et al. Endothelin-1-induced endothelial microvesicles impair endothelial cell function. J Appl Physiol (1985). 2020 Jun 1; 128(6): 1497-1505. doi: 10.1152/japplphysiol.00816.2019.

Cain MA, Salemi JL, Tanner JP, et al. Pregnancy as a window to future health: maternal placental syndromes and short-term cardiovascular outcomes. Am J Obstet Gynecol. 2016 Oct; 215(4): 484-484. doi: 10.1016/j.ajog.2016.05.047.

Chang X, Yao J, He Q, et al. Exosomes from Women with Preeclampsia Induced Vascular Dysfunction by Delivering sFlt (Soluble Fms-Like Tyrosine Kinase)-1 and sEng (Soluble Endoglin) to Endothelial Cells. Hypertension. 2018 Dec; 72(6): 1381-1390. doi: 10.1161/HYPERTENSIONAHA.118.11706.

Coban U, Takmaz T, Unyeli OD, Ozdemir S. Adverse Outcomes of Preeclampsia in Previous and Subsequent Pregnancies and the Risk of Recurrence. Sisli Etfal Hastan Tip Bul. 2021 Sep 24; 55(3): 426-431. doi: 10.14744/SEMB.2020.56650.

de Moreuil C, Alavi Z, Pasquier E. Hydroxychloroquine may be beneficial in preeclampsia and recurrent miscarriage. Br J Clin Pharmacol. 2020 Jan; 86(1): 39-49. doi: 10.1111/bcp.14131.

Drost JT, Maas AH, Holewijn S et al. Novel cardiovascular biomarkers in women with a history of early preeclampsia. Atherosclerosis. 2014; 237: 117–22. doi: 10.1016/j.atherosclerosis.2014.09.009.

Erez O, Romero R, Jung E, et al. Preeclampsia and eclampsia: the conceptual evolution of a syndrome. Am J Obstet Gynecol. 2022 Feb; 226(2S): 786-803. doi: 10.1016/j.ajog.2021.12.001.

Filipek A, Jurewicz E. Preeklampsja – choroba kobiet w ciąży [Preeclampsia - a disease of pregnant women]. Postepy Biochem. 2018 Dec 29; 64(4): 232-229. doi: 10.18388/pb.2018_146.

Frishman M, Radin M, Schreiber K. Hydroxychloroquine and antiphospholipid antibody-related pregnancy morbidity: a systematic review and meta-analysis. Curr Opin Obstet Gynecol. 2020 Oct; 32(5): 351-358. doi: 10.1097/GCO.0000000000000649.

Gabryel B, Bontor K, Jarząbek K, et al. Sulodexide up-regulates glutathione S-transferase P1 by enhancing Nrf2 expression and translocation in human umbilical vein endothelial cells injured by oxygen glucose deprivation. Arch Med Sci. 2019 Feb 11; 16(4): 957-963. doi: 10.5114/aoms.2019.82818.

Gamble D.T., Brikinns B., Myint P.K., et al. Hypertensive disorders of pregnancy and subsequent cardiovascular disease: Current national and international guidelines and the need for future research. Front. Cardiovasc. Med. 2019; 6: 55. doi: 10.3389/fcvm.2019.00055.

Garrido-Gimenez C, Mendoza M, Cruz-Lemini M et al. Angiogenic factors and long-term cardiovascular risk in women that developed preeclampsia during pregnancy. Hypertension. 2020; 76: 1808–16. doi: 10.1161/HYPERTENSIONAHA.120.15830.

Gaugler-Senden IP, Tamsma JT, van der Bent C et al. Angiogenic factors in women ten years after severe very early onset preeclampsia. PLoS One. 2012; 7: 436-37. doi: 10.1371/journal.pone.0043637.

Gottardi E, Lecarpentier E, Villette C, et al. Preeclampsia before 26 weeks of gestation: Obstetrical prognosis for the subsequent pregnancy. J Gynecol Obstet Hum Reprod. 2021 Mar; 50(3): 102000. doi: 10.1016/j.jogoh.2020.102000.

Hoppensteadt DA, Fareed J. Pharmacological profile of sulodexide. Int Angiol. 2014 Jun; 33(3): 229-35.

Kvehaugen A.S., Dechend R., Ramstad H.B., et al. Endothelial function and circulating biomarkers are disturbed in women and children after preeclampsia. Hypertension. 2011; 58: 63–69. doi: 10.1161/HYPERTENSIONAHA.111.172387.

Marques BCAA, Klein MRST, da Cunha MR, et al. Effects of Oral Magnesium Supplementation on Vascular Function: A Systematic Review and Meta-analysis of Randomized Controlled Trials. High Blood Press Cardiovasc Prev. 2020 Feb; 27(1): 19-28. doi: 10.1007/s40292-019-00355-z.

Masola V, Zaza G, Onisto M, et al. Glycosaminoglycans, proteoglycans and sulodexide and the endothelium: biological roles and pharmacological effects. Int Angiol. 2014 Jun; 33(3): 243-54.

Nakahara A, Nair S, Ormazabal V, et al. Circulating Placental Extracellular Vesicles and Their Potential Roles During Pregnancy. Ochsner J. 2020 Winter; 20(4): 439-445. doi: 10.31486/toj.20.0049.

Orabona R., Sciatti E., Vizzardi E., et al. Endothelial dysfunction and vascular stiffness in women with previous pregnancy complicated by early or late pre-eclampsia. Ultrasound Obstet. Gynecol. 2017; 49: 116–123. doi: 10.1002/uog.15893.

Orabona R., Vizzardi E., Sciatti E., et al. Insights into cardiac alterations after pre-eclampsia: An echocardiographic study. Ultrasound Obstet. Gynecol. 2017; 49: 124–133. doi: 10.1002/uog.15983.

Perera C, Zheng S, Kokkinos MI, et al. Decidual mesenchymal stem/stromal cells from preeclamptic patients secrete endoglin, which at high levels inhibits endothelial cell attachment invitro. Placenta. 2022 Aug; 126: 175-183. doi: 10.1016/j.placenta.2022.07.003.

Rana S, Lemoine E, Granger JP, et al. Preeclampsia: Pathophysiology, Challenges, and Perspectives. Circ Res. 2019 Mar 29; 124(7): 1094-1112. doi: 10.1161/CIRCRESAHA.118.313276.

Saleh L., van den Meiracker A.H., Geensen R., et al. Soluble fms-like tyrosine kinase-1 and placental growth factor kinetics during and after pregnancy in women with suspected or confirmed pre-eclampsia. Ultrasound Obstet. Gynecol. 2018; 51: 751–757. doi: 10.1002/uog.

Tomimatsu T, Mimura K, Matsuzaki S, et al. Preeclampsia: Maternal Systemic Vascular Disorder Caused by Generalized Endothelial Dysfunction Due to Placental Antiangiogenic Factors. Int J Mol Sci. 2019 Aug 30; 20(17): 42-46. doi: 10.3390/ijms20174246.

Tuzcu ZB, Asicioglu E, Sunbul M et al. Circulating endothelial cell number and markers of endothelial dysfunction in previously preeclamptic women. Am J Obstet Gynecol. 2015; 213: 533–e1–7. doi: 10.1016/j.ajog.2015.06.043.

Vahedian-Azimi A, Karimi L, Reiner Ž, et al. Effects of statins on preeclampsia: A systematic review. Pregnancy Hypertens. 2021 Mar; 23: 123-130. doi: 10.1016/j.preghy.2020.11.014.

Wu R, Wang T, Gu R, et al. Hypertensive Disorders of Pregnancy and Risk of Cardiovascular Disease-Related Morbidity and Mortality: A Systematic Review and Meta-Analysis. Cardiology. 2020; 145(10): 633-647. doi: 10.1159/000508036.